Frequency of Polycystic Ovarian Syndrome In Women Presenting with Acne Vulgaris – A Cross-Sectional Study

Asma Malik; Muhammad Farhan Shahid; Muhammad Khurram Ahmad; Ayesha Anwar; Aimen Sohrab; Muhammad Tayyab Iqbal

doi:10.51253/pafmj.v76iSUPPL-5.13129

Authors

Asma Malik Department of Dermatology, Pak Emirates Military Hospital/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
Muhammad Farhan Shahid Department Medicine, Pak Emirates Military Hospital/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
Muhammad Khurram Ahmad Department of Dermatology, Combined Military Hospital Rawalpindi /National University of Medical Sciences (NUMS) Pakistan
Ayesha Anwar Department of Dermatology, Pak Emirates Military Hospital/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
Aimen Sohrab Department of Dermatology, Pak Emirates Military Hospital/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
Muhammad Tayyab Iqbal Department of Dermatology, Pak Emirates Military Hospital/National University of Medical Sciences (NUMS), Rawalpindi Pakistan

DOI:

https://doi.org/10.51253/pafmj.v76iSUPPL-5.13129

Keywords:

Acne vulgaris, Global Acne Grading Scale (GAGS), Hirsutism, Hyperandrogenism, Polycystic Ovarian Syndrome (PCOS)

Abstract

Objective: To study the frequency of polycystic ovarian syndrome (PCOS) in women presenting with acne vulgaris in Dermatology outpatient department (OPD).

Study Design: Analytical cross-sectional study.

Place and Duration of Study: Department of Dermatology, Pak Emirates Military Hospital (PEMH), Rawalpindi, Pakistan, from May to Oct 2024.

Methodology: The study enrolled 104 women presenting to Dermatology OPD with face acne. Patients diagnosed with acne vulgaris by a dermatologist were advised blood tests for Luteinizing Hormone (LH)/ Follicle-stimulating hormone (FSH) ratio and pelvic ultrasound for ovarian cysts. Rotterdam Criteria were used to diagnose PCOS. The frequency of PCOS in acne vulgaris patients was assessed, along with the association of acne severity with PCOS and menstrual irregularities, and the relationship between Body Mass Index (BMI) and PCOS. Chi-square analysis was used to determine association between acne vulgaris and PCOS.

Results: The median age of enrolled patients was 33.50(14.00) years, and median BMI was 25.00(4.00) kg/m². All patients had acne vulgaris, which was graded using Global Acne Grading System (GAGS) where 34(32.70%) patients had mild acne, 30(28.80%) moderate, 21(20.20%) had moderately severe acne while severe acne was seen in 19(18.30%) patients. From the study population, PCOS was diagnosed using the Rotterdam Criteria in 42(40.40%) acne vulgaris patients and 62(59.60%) acne patients did not have underlying PCOS. Menstrual abnormalities were the most common clinical feature observed in the entire study population (n=104), with 52(50%) patients reporting oligomenorrhoea.

Conclusion: Underlying PCOS is frequent finding in women presenting with acne vulgaris, particularly with associated symptoms like..

Downloads

Download data is not yet available.

References

1. Vasam M, Korutla S, Bohara RA. Acne vulgaris: a review of the pathophysiology, treatment, and recent nanotechnology based advances. Biochem Biophys Rep. 2023; 36: 101578. https://doi.org/10.1016/j.bbrep.2023.101578

2. Espinosa NI, Cohen PR. Acne vulgaris: a patient and physician's experience. Dermatol Ther (Heidelb). 2020; 10(1): 1-14. https://doi.org/10.1007/s13555-019-00335-0

3. Oge' LK, Broussard A, Marshall MD. Acne vulgaris: diagnosis and treatment. Am Fam Physician. 2019; 100(8): 475-484.

4. Babar O, Mobeen A. Prevalence and psychological impact of acne vulgaris in female undergraduate medical students of Rawalpindi and Islamabad, Pakistan. Cureus. 2019; 11(9): e5722. https://doi.org/10.7759/cureus.5722

5. Heath C. Acne vulgaris. J Fam Pract. 2021; 70(7). https://doi.org/10.12788/jfp.0271

6. Azhar S, et al. Polycystic ovary syndrome, subfertility and vitamin D deficiency. J Coll Physicians Surg Pak. 2020; 30(5): 545-546. https://doi.org/10.29271/jcpsp.2020.05.545

7. Ndefo UA, Eaton A, Green MR. Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches. P T. 2013; 38(6): 336-355.

8. Chang S, Dunaif A. Diagnosis of polycystic ovary syndrome. Endocrinol Metab Clin North Am. 2021; 50(1): 11-23. https://doi.org/10.1016/j.ecl.2020.10.002

9. Abusailik MA, Muhanna AM, Almuhisen AA, Alhasanat AM, Alshamaseen AM, Bani Mustafa SM, et al. Cutaneous manifestation of polycystic ovary syndrome. Dermatol Rep. 2021; 13(2): 8799. https://doi.org/10.4081/dr.2021.8799

10. Jabeen S, Asad F, Rani Z, Khurshid K, Pal SS. Frequency of polycystic ovarian syndrome among patients presenting with acne. J Pak Assoc Dermatol. 2018; 28(3): 329-332.

11. Begum S, Hossain MZ, Rahman F, Banu LA. Polycystic ovarian syndrome in women with acne. J Pak Assoc Dermatol. 2012; 22: 24-29.

12. Gainder S, Sharma B. Update on management of polycystic ovarian syndrome for dermatologists. Indian Dermatol Online J. 2019; 10(2): -103. https://doi.org/10.4103/idoj.IDOJ_249_17

13. Bansal P, Sardana K, Vats G, Sharma L, Garga U, Khurana A. A prospective study examining trigger factors and hormonal abnormalities in adult female acne. Indian Dermatol Online J. 2020; 11(4): 544-549. https://doi.org/10.4103/idoj.IDOJ_500_19

14. Parker DJ, Stegehuis N. Evidenced-based nutritional therapy for the management of acne vulgaris in women with polycystic ovary syndrome. J Hum Nutr Diet. 2021; 40(3).

15. Gencoglu S. Relationship between elevated serum decorin levels and acne vulgaris in women with PCOS. Eur Rev Med Pharmacol Sci. 2024; 28(2): 457-462.

https://doi.org/10.26355/eurrev_202401_35044

16. Sas K, Reich A. High body mass index is a risk factor for acne severity in adolescents: a preliminary report. Acta Dermatovenerol Croat. 2019; 27(2): 81-85.

17. Shareef AR, Prasad PVS, Kaviarasan PK. Prevalence and pattern of PCOS in women presenting with acne, a hospital based prospective observational study. Int J Res Med Sci. 2018; 6(3): 899-903. https://doi.org/10.18203/2320-6012.ijrms20180611

18. Heng AHS, Chew FT. Systematic review of the epidemiology of acne vulgaris. Sci Rep. 2020; 10(1): 5754.

https://doi.org/10.1038/s41598-020-62715-3

19. Chanyachailert P, Chularojanamontri L, Chantrapanichkul P, Tuchinda P, Wongwananuruk T, Sardod P, et al. Adult female acne: clinical characteristics and factors significantly associated with polycystic ovary syndrome. Australas J Dermatol. 2021; 62(4). https://doi.org/10.1111/ajd.13700

20. Chandra M, Garg P, Vats K, Tibrewal AO. An observational study on prevalence and determinants of PCOS in women presenting with acne vulgaris to a tertiary care hospital in North India. Int J Community Med Public Health. 2021; 8(3): 1270-1275. https://doi.org/10.18203/2394-6040.ijcmph20210812

21. Ramezani Tehrani F, Behboudi-Gandevani S, Bidhendi Yaradi R, Saei Ghare Naz M, Carmina E. Prevalence of acne vulgaris among women with polycystic ovary syndrome: a systemic review and meta-analysis. Gynecol Endocrinol. 2021; 37(5): 392-405. https://doi.org/10.1080/09513590.2020.1859474

22. Carmina E, Dreno B, Lucky WA, Agak WG, Dokras A, Kim JJ, et al. Female adult acne and androgen excess: a report from the multidisciplinary androgen excess and PCOS committee. J Endocr Soc. 2022; 6(3): bvac003.

https://doi.org/10.1210/jendso/bvac003